Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib in Recurrent/Metastatic Squamous Head and Neck Carcinoma
NCT00408252Phase 2Terminated
- Start
- Feb 2007
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of sunitinib in head and neck squamous cell carcinoma (HNSCC). Started Feb 2007; status: terminated.
02
Drugs
sunitinib
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT00408252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00408252.